No abstract available
Keywords:
AF; ARISTOTLE; ASGE; American Society for Gastrointestinal Endoscopy; INR; NOAC; NSAID; PCC; PPI; PT; RE-LY; ROCKET-AF; RR; aPTT; activated partial thromboplastin time; apixaban for reduction in stroke and thromboembolic events in atrial fibrillation; atrial fibrillation; international normalized ratio; nonsteroidal anti-inflammatory drug; novel oral anticoagulant; prothrombin complex concentrate; prothrombin time; proton pump inhibitor; randomized evaluation of long term anticoagulant therapy; relative risk; rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anticoagulants / adverse effects*
-
Anticoagulants / pharmacology
-
Antithrombins / adverse effects
-
Antithrombins / pharmacology
-
Atrial Fibrillation / complications
-
Benzimidazoles / adverse effects
-
Benzimidazoles / pharmacology
-
Dabigatran
-
Gastrointestinal Hemorrhage / chemically induced*
-
Humans
-
Morpholines / adverse effects
-
Morpholines / pharmacology
-
Pyrazoles / adverse effects
-
Pyrazoles / pharmacology
-
Pyridines / adverse effects
-
Pyridines / pharmacology
-
Pyridones / adverse effects
-
Pyridones / pharmacology
-
Rivaroxaban
-
Stroke / etiology
-
Stroke / prevention & control*
-
Thiophenes / adverse effects
-
Thiophenes / pharmacology
Substances
-
Anticoagulants
-
Antithrombins
-
Benzimidazoles
-
Morpholines
-
Pyrazoles
-
Pyridines
-
Pyridones
-
Thiophenes
-
apixaban
-
Rivaroxaban
-
Dabigatran